pharmadog
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
the cabinet

Drugs

8,127 products tracked

★ save view↓export CSV
phase
allMarketedPhase 3Phase 2Phase 1Preclinical
sort
catalystsrecentname
therapeutic area
allOncology1831Infectious Disease718Cardiology425Pulmonology396Immunology371Ophthalmology368Dermatology300Women's Health131
viewlistcards
  • Marketed
    Ketalar
    Ketalar (ketamine hydrochloride)
    General Anesthetic Effect Par Pharmaceutical Inc3 cat
  • Marketed
    LOPERAMIDE HYDROCHLORIDE
    LOPERAMIDE HYDROCHLORIDE
    Diarrhea LNK International Inc (Inactive)3 cat
  • Marketed
    NEOSTIGMINE METHYLSULFATE
    NEOSTIGMINE METHYLSULFATE
    no indication$AMPH Amphastar Pharmaceuticals, Inc.3 cat
← prev
page 14 of 271
next →
Pain89
Neurology1
Marketed
OSENVELT
OSENVELT (DENOSUMAB-BMWO)
no indication
Celltrion Inc
3 cat
  • Marketed
    PROGESTERONE
    PROGESTERONE
    Female Infertility IBSA Institut Biochimique SA3 cat
  • Marketed
    PRUCALOPRIDE SUCCINATE
    PRUCALOPRIDE SUCCINATE
    Constipation SpecGx LLC3 cat
  • Marketed
    ROCURONIUM BROMIDE
    ROCURONIUM BROMIDE
    Muscle Relaxation Piramal Critical Care Inc3 cat
  • Marketed
    SITAGLIPTIN PHOSPHATE
    SITAGLIPTIN PHOSPHATE
    Type 2 Diabetes Merck Sharp & Dohme LLC3 cat
  • Marketed
    SODIUM ACETATE
    SODIUM ACETATE
    no indication$AMRX Amneal Pharmaceuticals, Inc.3 cat
  • Marketed
    SODIUM BICARBONATE
    SODIUM BICARBONATE
    no indication$AMRX Amneal Pharmaceuticals, Inc.3 cat
  • Marketed
    SODIUM PHENYLBUTYRATE
    SODIUM PHENYLBUTYRATE
    Carbamoyl-Phosphate Synthase I Deficiency Horizon Therapeutics USA Inc3 cat
  • Marketed
    URSODIOL
    URSODIOL
    Primary Biliary Cholangitis (Primary Biliary Cirrhosis) RK Pharma Inc3 cat
  • Marketed
    VARENICLINE TARTRATE
    VARENICLINE TARTRATE
    Keratoconjunctivitis Sicca (Dry Eye) Oyster Point Pharma Inc3 cat
  • adebrelimab
    no indication Jiangsu Hengrui Pharmaceuticals Co Ltd3 cat
  • Marketed
    aflibercept biosimilar
    Ahzantive (aflibercept-abzv)
    Diabetic Macular Edema Sam Chun Dang Pharm Co Ltd3 cat
  • Marketed
    avacincaptad pegol sodium
    Izervay (avacincaptad pegol sodium)
    Geographic Atrophy Astellas Pharma US Inc3 cat
  • Marketed
    capecitabine
    Capecitabine
    Colon Cancer Armas Pharmaceuticals Inc3 cat
  • Marketed
    cyclophosphamide
    Cyclophosphamide (cyclophosphamide [INN])
    Acute Lymphocytic Leukemia (ALL, Acute Lymphoblastic Leuk… Long Grove Pharmaceuticals LLC3 cat
  • Marketed
    dalfampridine ER
    Dalfampridine Mylan (dalfampridine)
    Hypokinesia Mylan Pharmaceuticals Inc3 cat
  • Marketed
    ensartinib hydrochloride
    Ensacove (ensartinib hydrochloride)
    Non-Small Cell Lung Cancer Xcovery Holdings Inc3 cat
  • Marketed
    evinacumab
    Evkeeza (evinacumab-dgnb)
    Homozygous Familial Hypercholesterolemia (HoFH)$REGN REGENERON PHARMACEUTICALS, INC.3 cat
  • Marketed
    futibatinib
    Lytgobi (futibatinib)
    Bile Duct Cancer (Cholangiocarcinoma) Taiho Oncology Inc3 cat
  • Marketed
    glofitamab
    Columvi (glofitamab-gxbm)
    Mantle Cell Lymphoma F. Hoffmann-La Roche Ltd3 cat
  • Marketed
    granisetron ER
    Sustol (granisetron)
    Chemotherapy Induced Nausea and Vomiting Heron Therapeutics Inc3 cat
  • Marketed
    inavolisib
    Itovebi (inavolisib)
    Human Epidermal Growth Factor Receptor 2 Positive Breast… F. Hoffmann-La Roche Ltd3 cat
  • Marketed
    lazertinib mesylate
    Lazcluze (lazertinib mesylate)
    Non-Small Cell Lung Cancer$JNJ JOHNSON & JOHNSON3 cat
  • Marketed
    lebrikizumab
    Ebglyss (lebrikizumab)
    Atopic Dermatitis (Atopic Eczema) Lilly USA LLC3 cat
  • levobupivacaine
    no indication Swami Dayanand Hospital3 cat
  • Marketed
    marstacimab
    Hympavzi (marstacimab-hncq)
    Hemophilia A (Factor VIII Deficiency)$PFE PFIZER INC3 cat
  • Marketed
    mirabegron ER
    Myrbetriq (mirabegron)
    Neurogenic Bladder Dysfunction Astellas Pharma US Inc3 cat